Egetis Therapeutics (EGTX.ST) traded up 5.62 % during a 24 hours period ending at 10:57 AM Central Europe on Wednesday 28th. One Egetis Therapeutics stock can currently be bought for about SEK 10.18 on popular exchanges. Current supply of Egetis Therapeutics stocks is 465 mn. Egetis Therapeutics has a current market capitalization of SEK 4.5 bn and approximately SEK 20.8 mn worth of Egetis Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Egetis Therapeutics has traded 31.32 % up. Simple moving average of last 200 days is at SEK 6.38. The highest price of past 52 weeks was recorded at SEK 10.14 on 10/08/2026. 52 weeks low was at SEK 3.62 on 11/26/2025.

Summary of the latest news for Egetis Therapeutics

EGETIS THERAPEUTICS AB has advanced the commercial launch of its drug Emcitate in the United States ahead of schedule, following approval by the FDA in late September. The medication represents the first and only approved treatment in the U.S. for peripheral thyrotoxicosis in patients—both children and adults—affected by the rare MCT8 deficiency, also known as Allan‑Herndon‑Dudley syndrome. Prior to the launch, the company established a patient‑support program called Rarelink in partnership with Pantherx Rare Pharmacy to facilitate access to therapy and provide clinical assistance. This development marks a significant milestone for EGETIS in bringing a novel therapy to a niche patient population in the U.S. market.

Here is how related stocks have performed in the past 24 hours:

  • Tangen Industrikapital (TANGENB.ST) traded up 0.58 % and now trades at SEK 94.05. Tangen Industrikapital has a market capitalisation of SEK 5.1 bn. Tangen Industrikapital has a current price to earnings ratio of 22.95.

  • Salix (SALIX.ST) traded down -0.16 % and now trades at SEK 62.2. Salix has a market capitalisation of SEK 5 bn. Current price/earnings ratio for Salix is 24.71.

  • Morrow Bank (MORROW.ST) traded up 0.66 % and now trades at SEK 15.54. Morrow Bank has a market capitalisation of SEK 4.8 bn. Morrow Bank has a current price to earnings ratio of 14.4.

  • Haypp (HAYPP.ST) traded up 1.64 % and now trades at SEK 173.8. Current market capitalisation for Haypp is SEK 5.4 bn. Haypp has a current price to earnings ratio of 592.91.

  • Viaplay (VPLAY-A.ST) traded up 7.48 % and now trades at SEK 2.3. Current market capitalisation for Viaplay is SEK 5.3 bn. Viaplay Group AB, a Scandinavian entertainment provider, remains a minority stakeholder in the French media conglomerate Canal + Group. Recent developments indicate that Viaplay’s position is largely tied to its minority shareholdings in the broader group, which also owns stakes in other regional platforms such as Dailymotion and UGC. The company has not announced any major strategic moves or changes in ownership structure, and its activities continue to be focused on content distribution and streaming services across the Nordic market. No significant financial performance updates or market‑movement catalysts have been reported for Viaplay Group AB in the available information.

About Egetis Therapeutics

Egetis Therapeutics AB is a pharmaceutical drug development company operating in the health care sector with a focus on projects in late-stage development for the treatment of rare and niche diseases with significant unmet medical needs in the orphan drug segment.